ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,122, issued on June 17, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Anti-ASGR-1 monoclonal inhibitory antibodies" was invented by Paul Nioi (Wellesley, Mass.), Peter Coward (San Francisco), Christopher Murawsky (Vancouver, Canada), Derek E. Piper (Santa Clara, Calif.), Fernando Garces (San Mateo, Calif.) and Brian Mingtung Chan (Port Coquitlam, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antigen binding proteins that interact with ASGR, ASGR-1 and/or ASGR-2 are described as well as methods of making and using such antigen binding proteins. Methods of treating and preventing cardiovascular disease by administering a pharmaceuticall...